Высокоэффективная маркировка нервно-паралитических волокон в очищенных тканях для легкой микроскопии.
Обработка статьи · этапы, ошибки и управление
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Rojas-Rodríguez Marta, Imbimbo Elisa, Capitini Claudia, Costantini Irene, Mazzamuto Giacomo, Pavone Francesco Saverio, Silvestri Ludovico, Calamai Martino
Аннотация
Оригинал публикации
High efficiency labeling of nerve fibers in cleared tissue for light-sheet microscopy.
BACKGROUND: Tissue clearing techniques combined with light-sheet fluorescence microscopy (LSFM) enable high-resolution 3D imaging of biological structures without physical sectioning. While widely used in neuroscience to determine brain architecture and connectomics, their application for spinal cord mapping remains more limited, posing challenges for studying demyelinating diseases like multiple sclerosis. Myelin visualization in cleared tissues is particularly difficult due to the lipid-removal nature of most clearing protocols, and alternative immunolabeling approaches failed to reach satisfying results.
NEW METHOD: To overcome these limitations, we developed a novel protocol named HELF -High Efficiency Labeling of Fibers- which takes advantage of a fluorescently labeled aminosterol, trodusquemine, which displays a strong affinity for cholesterol-rich membranes, and a supplementary round of fixation with glutaraldehyde.
RESULTS AND COMPARISON WITH EXISTING METHODS: The labeling with trodusquemine was tested in combination with various established tissue clearing techniques and compared with HELF, which resulted to be the best approach for providing high-brightness myelin staining in mouse spinal cord and brain, and in human brain samples. Finally, we demonstrated that HELF can be used to stain and image with LSFM a whole cleared mouse spinal cord.
CONCLUSIONS: Our data support the potential use of HELF coupled to LSFM as a practical tool for the evaluation of novel therapeutics for remyelination in preclinical models of CNS diseases.